Visit/518394/a-healthier-outlook-for-biotech
Five funds to buy into biotech's healthy future
The biotech sector has struggled over the past year, but it remains a solid long-term investment. Here are five good ways to buy in.
26 Nov 2019
Visit/511795/syncona-how-to-invest-in-the-biotech-boom
The best way to play the biotech boom
Syncona is an unusual investment trust that invests in promising privately held biotech companies. It should be a core holding in any portfolio, says …
30 Jul 2019
Visit/511814/how-stem-cells-are-changing-the-face-of-medicine
How stem cells are changing the face of medicine
We have only just started getting to grips with the vast life-saving potential of stem cells, the basic building blocks of the body. Dr Mike Tubbs exp…
26 Jul 2019
Visit/510699/dna-genetics-epigenetics-bespoke-medicine
How to profit from the age of bespoke medicine
Doctors have traditionally approached diseases with a one-size-fits-all model. But advances in genetics and artificial intelligence are making medical…
11 Jul 2019
Visit/504987/the-drugs-dont-work-stopping-the-spread-of-the-superbugs
The drugs don’t work: stopping the spread of the superbugs
Antibiotic resistance could turn medical inconveniences into death sentences and become a bigger killer than cancer. Governments and pharmaceutical co…
11 Apr 2019
Visit/504470/immunotherapy-new-hope-in-the-battle-against-cancer
Immunotherapy: new hope in the battle against cancer
Immunotherapy is a burgeoning sector that heralds a breakthrough against the world’s second-most deadly disease. Dr Mike Tubbs explains how investors …
4 Apr 2019
Visit/499935/invest-in-helium-biotech-and-uk-small-caps-in-2019
Invest in helium, biotech, and UK small caps in 2019
We asked our contributors to choose their favourite investment ideas from around the world for this year and beyond. Here’s what they came up with.
27 Dec 2018
Visit/496787/worldwide-healthcare-trust-investing-in-healthcare-innovation
Investing in healthcare innovation
The Worldwide Healthcare Trust provides investors with access to exciting opportunities, says Max King.
19 Oct 2018
Visit/495857/where-to-find-the-pick-of-the-bunch-in-biotech
Where to find the pick of the bunch in biotech stocks
Professional investor Ailsa Craig picks three biotech stocks generating revenues and profits, and which have long-term patent protection.
5 Oct 2018
Visit/494414/a-memorable-day-for-biogen-investors
A memorable day for Biogen investors
Biotech company Biogen’s promising treatment for the most common cause of dementia has just cleared a key hurdle.
7 Sep 2018
Visit/491998/three-biotech-stocks-to-buy-now
Three biotech stocks to buy now
Professional investor Daniel Koller picks three cutting edge three biotech stocks to buy now.
27 Jul 2018
Visit/488304/become-a-diy-biotech-venture-capitalist
Become a DIY biotech venture capitalist
A new equity crowdfunding platform wants to become the go-to place for investors in early-stage life science companies.
18 May 2018
Visit/486743/genome-the-pharmas-making-pills-tailored-to-your-genes
The pharmas making pills tailored to your genes
Reading your genome is becoming easier and cheaper. That makes it possible to figure out which medicines will work for you. Dr Mike Tubbs picks the co…
19 Apr 2018
Visit/477909/how-to-invest-in-biotech-stocks-alzheimers-parkinsons-ms
How to invest in the next big medical breakthrough
There is currently no cure for MS, Alzheimer’s and Parkinson’s diseases but research gallops on. There will be big rewards for the first drug company …
7 Dec 2017
Visit/474925/the-fountain-of-youth-will-spout-money-for-investors
The fountain of youth will spout money for investors
Life expectancy has doubled in just a few generations, and the trend will continue, Jim Mellon tells Merryn Somerset Webb. That’s an opportunity for …
20 Oct 2017
Visit/473733/how-to-invest-in-the-fight-against-cancer
How to invest in the fight against cancer
A new generation of anti-cancer drugs looks promising. There are four main ways to invest, with varying levels of risk. Dr Michael Tubbs explains.
29 Sep 2017
Visit/473734/worldwide-healthcare-trust-buy-into-this-exceptional-healthcare-trust
Buy into this exceptional healthcare trust
Investors have an opportunity to buy into an exceptional trust in an undervalued growth sector. They should take it, says Max King.
29 Sep 2017
Visit/473656/how-to-profit-as-britain-piles-on-the-pounds
How to profit as Britain piles on the pounds
The world is getting fatter – and with no easy solution to obesity in sight, investing in healthcare providers and food and drink makers could bring b…
28 Sep 2017
Visit/464254/invest-in-cutting-edge-healthcare
Invest in cutting-edge healthcare
Max King looks at one fund allowing investors to put their money in cutting-edge medical research.
24 Mar 2017
Visit/457649/the-pharma-price-gouging-scandal
The pharma price-gouging scandal
Pharmaceutical companies have hit the headlines for hiking prices for life-saving drugs by shocking amounts. What’s going on? Simon Wilson reports.
25 Dec 2016
Visit/456374/three-promising-sectors-for-2017
Three promising sectors for 2017
Max King tips a host of funds in various sectors to do well in the forthcoming year.
9 Dec 2016
Visit/455829/lilly-fails-alzheimers-test
Lilly fails Alzheimer’s test
Eli Lilly’s new treatment has proved ineffective in late-stage trials – yet another blow for a struggling sector, says Ben Judge.
2 Dec 2016
Visit/455353/who-will-prosper-under-trump
Who will prosper under Trump?
Now that the markets have got over the shock of a Trump victory in the US presidential election, David C Stevenson looks at which funds to buy.
25 Nov 2016
Visit/454239/earn-a-3-5-yield-from-healthcare
Earn a 3.5% yield from healthcare
David C Stevenson looks at the best healthcare and biotech investment trusts to tuck away in your portfolio.
11 Nov 2016
Visit/453655/novo-nordisk-pharma-giant-takes-a-tumble
Novo Nordisk: Pharma giant takes a tumble
Novo Nordisk shocked investors by slashing its growth forecasts. The new CEO faces a tough start, says Ben Judge.
4 Nov 2016
Visit/450577/how-we-can-profit-from-winning-the-battle-against-ageing
How we can profit from winning the battle against ageing
We’re now living longer than ever – only to suffer from diseases of old age. New therapies promise a new lease of life for the elderly – and big profi…
22 Sep 2016
Visit/419417/three-long-term-investment-ideas-for-the-brave
Three long-term investment ideas for the brave
Professional investor Rebecca O'Keeffe looks at three long-term investment ideas – biotech, Indian equities, and smaller companies – and picks the bes…
18 Dec 2015
Visit/416788/four-promising-biotech-stocks-to-buy-now
Four promising biotech stocks to buy now
The recent correction in biotech stocks was overdone, says professional investor Dr Daniel Koller. Here, he picks four biotech companies to buy now.
27 Nov 2015
Visit/416877/pfizer-allergan-deal-combines-botox-and-viagra
Pfizer-Allergan megadeal combines Botox and Viagra
US drug giant Pfizer is to buy Ireland-based Allergan for $168bn, setting a new record for a merger in the pharmaceuticals industry.
26 Nov 2015
Visit/415170/gene-editing-a-cut-and-paste-cure-for-cancer
Gene editing: a cut-and-paste cure for cancer
Recent advances in the field of gene editing open up a multitude of exciting medical possibilities, says Simon Wilson. But the moral implications shou…
14 Nov 2015
Visit/414480/five-game-changing-technologies
Invest in the future: five game-changing technologies
Over the past 15 years, technology has revolutionised industries across the globe. Matthew Partridge looks at what will shape the next 15.
5 Nov 2015
Visit/411607/chart-of-the-week-biotech-spawns-a-monster
Chart of the week: biotech spawns a monster
Valuations in the Nasdaq Biotechnology index have soared in recent years. But have we already seen the top?
16 Oct 2015
Visit/406687/two-biotech-stocks-to-buy-in-the-arms-race-against-bugs
Two biotech stocks to buy in the arms race against bugs
With antibiotic resistance costing the US healthcare system $20bn a year, there's profit in battling bugs. Matthew Partridge looks at the problem and …
4 Sep 2015
Visit/405472/the-biggest-threat-to-modern-medicine-could-be-a-big-opportunity-too
The biggest threat to modern medicine could be a big opportunity too
A crisis is looming which threatens to undermine the basis of modern medicine. As Matthew Partridge explains, that creates opportunities for drugs com…
21 Aug 2015
Visit/404432/a-bubble-in-the-biotech-sector
A bubble in the biotech sector?
Growth-starved investors have piled into the Nasdaq in recent years, swelling the exchange's biotech index.
14 Aug 2015
Visit/403552/shires-30bn-move-on-baxalta
Shire’s $30bn move on Baxalta
Pharma giant Shire has made an unsolicited $30bn all-share offer for America’s Baxalta.
6 Aug 2015
Visit/400058/three-biotech-merger-targets-to-buy-now
Three biotech merger targets to buy now
Professional investor Ailsa Craig picks three biotech stocks that are ripe for takeover.
10 Jul 2015
Visit/386234/chart-of-the-week-the-biotech-bubble
Chart of the week: The biotech bubble
The Nasdaq Biotechnology index has risen almost sixfold in the past ten year. In the past five, it has quadrupled.
3 Apr 2015
Visit/382781/three-of-the-best-biotech-stocks-to-buy-now
Three of the best biotech stocks to buy now
Biotechnology firms are benefiting from demand from ageing populations. But as Dr Daniel Koller explains, there’s more to the biotech boom than that.
6 Mar 2015
Visit/373036/three-biotech-stocks-to-buy
Three biotech stocks to buy as the sector comes of age
Investment manager Carl Harald Janson tips three biotech stocks to profit from the full range of opportunities this exciting sector has to offer.
16 Jan 2015
Visit/354295/an-exciting-future-for-tech-stocks
An exciting future for tech stocks
We live in a golden age of unprecedented technological change. Smart investors should get in early, says Jim Mellon.
30 Oct 2014
Visit/354275/invest-for-a-high-tech-future
Invest for a high-tech future
Technological change is everywhere, says Merryn Somerset Webb. Investors who don't want to be left behind should read Jim Mellon's new book.
30 Oct 2014
Visit/353660/money-morning-how-maurice-saatchi-is-boosting-the-biotech-industry
How Maurice Saatchi is boosting the biotech industry
Biotech companies will soon be able to get new drugs to patients much faster. That's good news for patients and investors, says Matthew Partridge.
27 Oct 2014
Visit/349255/share-tips-angle-agl-parsortix-cancer-treatment
This company could have made a breakthrough in cancer treatment
The best way to improve cancer treatment is early diagnosis. And this small-cap biotech company may have the key to doing just that, says Matthew Part…
23 Sep 2014
Visit/332056/money-morning-cancer-treatment-astrazeneca-azn
A revolutionary new cancer treatment – and the blue-chip stock set to benefit
A new kind of cancer therapy could make a big difference to survival rates - and transform the fortunes of one big UK drugs company. Matthew Partridge…
1 Aug 2014
Visit/330217/how-to-invest-in-the-battle-against-ageing
How to invest in the battle against ageing
As life expectancy increases, pharmas and biotechs pioneering treatments for the diseases of old age will profit handsomely, says Matthew Partridge.
17 Jul 2014
Visit/328276/how-you-could-profit-in-the-hunt-for-new-antibiotics
How you could profit in the hunt for new antibiotics
The number of antibiotic-resistant bacteria is rising fast. But the search is on to find new drugs to combat them. Matthew Partridge explains how you …
3 Jul 2014
Visit/317777/drug-company-deals-give-markets-a-shot-in-the-arm
Drug company deals give markets a shot in the arm
A spate of merger deals between Big Pharma stocks has given the flagging sector a much-needed boost.
24 Apr 2014
Visit/merryns-blog/drug-companies-tax-inversion-dodge-could-backfire
Drug companies' 'tax inversion' dodge could backfire
Drugs companies relocating their headquarters via 'tax inversion' is a neat tax trick. But it could end up hitting their shares.
24 Apr 2014